Neimeth International Pharmaceutical Plc was founded in 1957.
The company is the resultant company from the Mazi Sam I Ohuabunw-led Management-Buy-Out of the 60% equity holding of Pfizer Inc. New York, USA in Pfizer Products Plc. This Management-Buy-Out took place in May 1997 when Pfizer Inc. in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management.
Before the brand name Neimeth International Pharmaceuticals Plc.,the Company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms. During the 40-year period (1957-1997), the Company established the first pharmaceutical manufacturing plant in Nigeria at Aba, which was destroyed during the Nigerian civil war. It then set up and opened the most modern pharmaceutical plant in the West African sub-region in 1976 at Oregun, Lagos. This represents great milestones for a Company that started as a trading venture in 1957 at a location in Ebute Metta, Lagos.
BOARD OF DIRECTORS
Dr. A. B. C Orjiako – Chairman
Pharm. Matthew O. Azoji - Managing Director/CEO
Mrs. Temitayo O. Nelson - Executive Director, Finance
Mazi Sam I. Ohuabunwa, - (OFR) - Non-Executive Director
Engr. Godwin E. Omene - (Non-Executive Director)
Prof. Elijah N. Sokomba - (Non-Executive Director)
Professor Maurice M. Iwu - (Non-Executive Director)
Thomas Tunbosun Osubu - (Non-Executive Director)
Phar. Sir. Ike Onyechi - (Non-Executive Director)
Mrs. Bashirat O. Odunewu (Independent Non-Executive Director).
Mrs. Roseline A. Oputa (Executive Director, Sales and Marketing)
Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun, Lagos.
Phone: +2349032543202 or +2348159491935
Please login to give a review.
The equity market closed flat on Tuesday as the All-Share Index (ASI) rose by 1.22 basis points or 0.002 per cent to close at 49,416.18 from 49,414.96...
Matthew Azodi, Managing Director/ Chief Executive Officer, Neimeth Pharmaceuticals Plc, has said the company is committed to its strategic expans...
Following the completion of the board meeting of Neitmeth International Pharmaceuticals Plc held in Lagos, the company has decided to float a rights i...
The equity market returned to the green zone following impressive returns from NESTLE (+2.87%), UCAP (+3.31%), and NB (+3.01%). Thus, the all-shar...
Traders were less optimistic as the market ended trading with the All-share index falling by 0.05% to close at 43,707.30 basis points on Wednesday. Th...
The Nigerian Stock Exchange (NSE) market closed with 4,016.00 deals on Thursday, March 25th, 2021, lower than the 4,018.00 deals on Wednesday, March 2...
The Nigerian Stock Exchange (NSE) market closed with 4,311.00 deals on Friday, March 19th, 2021, higher than the 4,040.00 deals on Thursday, March 18t...
The Nigerian Stock Exchange (NSE) market closed with 4,103.00 deals on Wednesday, March 17th, 2021, lower than the 4,192.00 deals on Tuesday, March 16...
The Nigerian Stock Exchange (NSE) market closed with 4,437.00 deals on Wednesday, March 10th, 2021, lower than the 4,616.00 deals on Tuesday, March 9t...
The Nigerian Stock Exchange (NSE) market closed with 4,616.00 deals on Tuesday, March 9th, 2021, lower than the 4,655.00 deals on Monday, March 8th, 2...
The Nigerian Stock Exchange (NSE) market closed with 4,673.00 deals on Monday, March 1st, 2021, higher than the 4,465.00 deals on Friday, Februa...
The Nigerian Stock Exchange (NSE) market closed with 4,393.00 deals on Friday, February 19th, 2021, lower than the 4,972.00 deals on Thursday, Februar...
